期刊文献+

荷非小细胞肺癌裸鼠体内^(131)I-17-AAG的分布及其抗癌潜力

Biodistribution and anti-cancer potential of ^(131)I-17-AAG in NSCLC xenograft-bearing nude mice
原文传递
导出
摘要 目的:探讨131I-17-丙基胺基-17-去甲氧基格尔德霉素(131I-17-AAG)在荷瘤裸鼠体内的生物学分布及其抗癌机制。方法:通过不同给药方式(131I-17-AAG间质给药或静脉给药、Na131I间质给药对照及竞争性显像),显像比较12只模型鼠体内分布情况,每只5.55MBq0.1mL。1周后处死取瘤,电镜和免疫组化检测细胞凋亡和Ki-67、Bcl-2蛋白表达情况,设空白对照组(n=3)。另取24只,分别通过间质或尾静脉注射131I-17-AAG(每只1.85MBq0.1mL),不同时间处死,取血并测主要组织脏器的放射性计数率值。结果:显像提示,间质注射131I-17-AAG瘤体内放射性浓聚并长时间滞留,体内分布实验进一步证实;尾静脉给药瘤体内存在一定放射性摄取,药物体内清除较快;Na131I注射后迅速排出体外,无瘤内滞留;竞争性显像示瘤内摄取降低。电镜观测给药组较对照组肿瘤增长抑制显著。Bcl-2和Ki-67阳性表达率131I-17-AAG给药组要低于对照组。不同给药组组间比较及与对照组比较差异有统计学意义,Pmax=0.004。结论:131I-17-AAG间质给药在瘤组织内有明确药代学分布和药效学作用,可行进一步肿瘤治疗研究。 OBJECTIVE:To study the biodistribution and therapeutic efficiency of 131^I-17-AAG in human non-small cell lung cancer(NSCLC) xenografts in mice.METHODS:In vivo imaging was performed through 131^I-17-AAG intratumoral injection or tail veil injection,Na131I intratumoral injection and the blocking imaging group,using 12 xenografts with dosage of 5.55 MBq in 0.1 mL solution per mouse.The mice were sacrificed and tumor tissues were separated.Examinations were done through electron microscopy for tumor cell apoptosis observation and through immunohistochemistry assay for Bcl-2 and Ki-67 expression,compared with blank control (n=3).Another 24 xenografts through 131^I-17-AAG intratumoral or intravenous delivery (1.85 MBq in 0.1 mL solution per mouse) were sacrificed at different time points.The blood and major organs were obtained for radioactivity measurement.RESULTS:In vivo imaging indicated tumor retention by 131^I-17-AAG intratumoral injection persisted for a long time,evidenced by the results of biodistribution study.While tumor uptake in tail veil injection group was not obvious but with a rapid systemic clearance,and Na131I control group had a rapid radioactivity clearance without tumor retention.In the blocking group,tumor uptake decreased significantly compared with the unblocked group.131^I-17-AAG injection groups had more tumor inhibition efficacy observed by electron microscopy and lower Bcl-2 and Ki67 expression than control groups.There were statistical significance among 131^I-17-AAG groups and control groups (Pmax=0.004).CONCLUSION:131^I-17-AAG through intratumoral injection has certain pharmacodynamic distribution and effects on tumor tissues and may have great potential for tumor therapy.
出处 《中华肿瘤防治杂志》 CAS 2010年第3期177-181,共5页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30470500) 江苏省普通高校研究生科研创新计划项目(CX09B_068Z)
关键词 非小细胞肺 同位素标记 小鼠 carcinoma non-small cell lung Isotope labeling mice nude
  • 相关文献

参考文献11

  • 1Tse A N, Klimstra D S, Gonen M,et al. A phase Ⅰ dose-escalation study of irinotecan in combination with 17 allylamino-17-clemethoxygeldanamycin in patients with solid tumors[J]. Clin Cancer Res,2008,14(20) :6704-6711.
  • 2Ramalingam S S, Egorin M J, Ramanathan R K, et al. A phase Ⅰ study of 171allylamino 17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignancies[J]. Clin Cancer Res,2008,14(11):3456-3461.
  • 3Koga F, Kihara K, Neckers L. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90[J]. Antieaneer Res,2009,29(3) :797-807.
  • 4Powers M V, Workman P. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors[J]. Endocr Relat Cancer, 2006,13 (Suppl) : 125-135.
  • 5Kamal A, Thao L, Sensintaffar J, et al. A high affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors [J]. Nature,2003,425(4):407-410.
  • 6张剑军,徐惠绵,阎影,王振宁,赵宜良,张涛,赵岩.热休克蛋白70和90α在人胃癌组织中表达及其与胃癌生物学行为的关系[J].中华肿瘤防治杂志,2006,13(7):495-497. 被引量:7
  • 7Jalava P, Kuopio T, Juntti-Patinen L, et al. I67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index[J]. Histopathology, 2006,48 (6):674-682.
  • 8时京,孔垂泽,刘贤奎,刘奔,张莹,孙志熙.Bcl-2基因在人膀胱癌细胞中表达对CTL凋亡诱导作用的影响[J].中华肿瘤防治杂志,2007,14(14):1073-1076. 被引量:3
  • 9李琪佳,王峰,付文娟,孙瑞军,白俊清,王志强.骨肉瘤组织FLIP和FADD及Caspase-8蛋白表达与细胞凋亡相关性的研究[J].中华肿瘤防治杂志,2009,16(22):1797-1800. 被引量:4
  • 10Banerji U, O'Donnell A, Scurr M, et al. Phase I pharmacoki netic and pharmacodynamie study of 17 allylamino, 17-deme thoxygeldanamycin in patients with advanced malignancies[J]. Clin Oncol,2005,23(18) :4152-4161.

二级参考文献25

  • 1时京,孔垂泽,孙志熙,王侠,杨绍波.丝裂霉素C联合抗Fas单抗、C_2神经酰胺对人膀胱癌T24细胞的抑制作用[J].中华外科杂志,2005,43(22):1478-1479. 被引量:2
  • 2殷占新,韩国宏,时永全,孙安华,吴开春,丁杰,樊代明.凋亡相关基因Fas和FasL在胰腺癌组织中的表达[J].中华肿瘤防治杂志,2006,13(4):283-286. 被引量:2
  • 3刘贤奎,孔垂泽,时京.转染Bcl-2基因的膀胱癌细胞多药耐药性研究[J].中华肿瘤防治杂志,2006,13(15):1151-1153. 被引量:4
  • 4Krueger A, Baumann S, Krammer P H, et al. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis [J]. Mol Cell Biol, 2001, 21(24): 8247-8254.
  • 5Carrington P E, Sandu C, Wei Y, et al. The structure of FADD and its mode of interaction with procaspase-8 [J]. Mol Cell, 2006, 22(5):599-610.
  • 6Sohn D, Schulze O K, Janicke R U, et al. caspase-8 can be activated by interchain proteolysis without receptor-triggered dimmerization during drug-induced apoptosis [J]. J Biol Chem, 2005, 280(7): 5267-5273.
  • 7Longley D B, Wilson T R, McEwan M, et al. cFLIP inhibits chemotherapy induced colorectal cancer cell death[J]. Onco gene, 2006, 25(6):838-848.
  • 8Kinoshita H, Yoshikawa H, Shiiki K, et al. Cisplatin (CDDP) sensitizes human osteosarcoma cell to Fas/CD95 mediated apoptosis by down-regulating FLIP-L expression[J]. Int J Cancer, 2000,88(6) : 986-991.
  • 9Algeciras-Schimnieh A, Barnhart B C, Peter M E. Apoptosis-in dependent functions of killer caspases[J]. Curr Opin Cell Biol, 2002,14(6) : 721-726.
  • 10Fulda S, Dbatine K M. IFN gamma sensitizes for apoptosis by upregulating caspase-8 expression through the Statl pathway [J]. Oncogene, 2002, 21(15): 2295-2308.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部